Singular Genomics Sys Q2 EPS $(0.35) Beats $(0.37) Estimate, Sales $505.00K Miss $1.15M Estimate
Portfolio Pulse from vinayak@benzinga.com
Singular Genomics Sys (NASDAQ:OMIC) reported Q2 losses of $(0.35) per share, beating the analyst consensus estimate of $(0.37) by 5.41%. However, the company's quarterly sales of $505.00K missed the analyst consensus estimate of $1.15M by 56.09%.
August 09, 2023 | 8:23 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Singular Genomics Sys reported better than expected Q2 EPS but missed on sales. This mixed result could lead to volatility in the stock price.
Singular Genomics Sys reported a better than expected EPS, which is a positive signal for investors. However, the company missed the sales estimate, which could be a concern. This mixed result could lead to volatility in the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100